Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Other Operating Expenses (2016 - 2025)

Fortress Biotech has reported Other Operating Expenses over the past 12 years, most recently at $6.5 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $6.5 million for Q4 2025, up 170.7% from a year ago — trailing twelve months through Dec 2025 was $25.2 million (up 6.28% YoY), and the annual figure for FY2025 was $25.2 million, up 6.28%.
  • Other Operating Expenses for Q4 2025 was $6.5 million at Fortress Biotech, down from $6.8 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for FBIO hit a ceiling of $21.4 million in Q3 2021 and a floor of -$6.1 million in Q4 2021.
  • Median Other Operating Expenses over the past 5 years was $6.8 million (2024), compared with a mean of $6.8 million.
  • Biggest five-year swings in Other Operating Expenses: tumbled 80.61% in 2023 and later surged 277.5% in 2024.
  • Fortress Biotech's Other Operating Expenses stood at -$6.1 million in 2021, then skyrocketed by 226.57% to $7.7 million in 2022, then dropped by 21.17% to $6.0 million in 2023, then tumbled by 60.25% to $2.4 million in 2024, then skyrocketed by 170.7% to $6.5 million in 2025.
  • The last three reported values for Other Operating Expenses were $6.5 million (Q4 2025), $6.8 million (Q3 2025), and $6.0 million (Q2 2025) per Business Quant data.